跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,037 条关于
“PDGFRA exon 18 mutation”
全部
15,037
临床试验
8,780
药物
756
机构
124
资讯
5,377
4个月前
Ayvakit (Avapritinib): High Response Rates in Rare Cancers and Mastocytosis, With Critical Safety Monitoring Requirements
去年
Extended Imatinib Therapy Shows Promise in High-Risk GIST Patients as Novel Agents Enter Clinical Development
去年
Zipalertinib Shows Promise in NSCLC with EGFR Exon 20 Insertion Mutations
9个月前
Ractigen Therapeutics Initiates First-in-Human Trial of RAG-18 for Duchenne Muscular Dystrophy
去年
CRISPR Repairs Limb-Girdle Muscular Dystrophy 2B Mutation and Phenotypes in Patient-Derived Cells
去年
Biocartis Achieves First IVDR Class C Companion Diagnostic Certification for EGFR Mutation Test in Europe
去年
Ripretinib Demonstrates Efficacy as Neoadjuvant Therapy for GIST in First Case Report
去年
Sunvozertinib NDA Submitted to FDA for EGFR Exon 20+ NSCLC
去年
Ascidian Therapeutics Advances RNA Exon Editing Platform with Key Leadership Appointments and Clinical Progress
2年前
Zipalertinib Shows Promise in EGFR Exon 20-Mutated NSCLC After Amivantamab Failure
第 1 页,共 538 页
上一页
下一页